Skip to main content
Premium Trial:

Request an Annual Quote

GeneGo Licenses Datamining and Pathway Analysis Platform to TGen

NEW YORK, May 16 (GenomeWeb News) - The Translational Genomics Research Institute has licensed GeneGo's datamining and pathway analysis platform, MetaCore, the St. Joseph, Mich.-based company said today.

 

"GeneGo enables our scientists to generate global pathways and smaller targeted networks," said Edward Suh, chief information officer of TGen, in a company statement.

 

Last week, GeneGo licensed its MetaCore platform to Exelixis and Procter & Gamble Pharmaceuticals.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.